ViGenCell Inc. (KOSDAQ:308080)
South Korea · Delayed Price · Currency is KRW 4,370.00
-145.00 (-3.21%)
At close: Nov 6, 2026
ViGenCell Market Cap
ViGenCell has a market cap or net worth of 89.58 billion as of November 5, 2026. It is the 27,594th most valuable company in the world and the 1,271st biggest in South Korea. Its market cap has increased by 29.03% in one year.
Market Cap
89.58B
Enterprise Value
52.29B
Revenue
278.95M
Global Rank
Country Rank
#1,271 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 25, 2021, ViGenCell's market cap has decreased from 561.23B to 89.58B, a decrease of -84.04%. That is a compound annual growth rate of -29.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 89.58B | -55.18% |
| Dec 30, 2025 | 199.87B | 315.01% |
| Dec 30, 2024 | 48.16B | -57.05% |
| Dec 28, 2023 | 112.12B | -17.15% |
| Dec 29, 2022 | 135.32B | -61.11% |
| Dec 30, 2021 | 347.95B | -38.00% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 126.37B |
| Y-Biologics | 125.39B |
| AriBioLab | 111.08B |
| TiumBio | 109.49B |
| Cell Biotech | 101.91B |
| Prestige Biologics | 91.67B |
| Choong Ang Vaccine Laboratory | 83.68B |
| BIO-FD&C | 78.35B |